Go Pro
OTCMKTS:TCNNF

Trulieve Cannabis (TCNNF) Stock Price, News & Analysis

Trulieve Cannabis logo
$11.86 0.00 (0.00%)
As of 07/31/2026

About Trulieve Cannabis Stock (OTCMKTS:TCNNF)

Advanced

Key Stats

Today's Range
$11.86
$11.86
50-Day Range
$7.50
$13.00
52-Week Range
$3.25
$13.28
Volume
N/A
Average Volume
378,093 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Trulieve Cannabis Corp. is a vertically integrated cannabis operator and retailer, offering a full suite of services from cultivation and processing to distribution and sales. The company develops, manufactures and markets a diverse range of cannabis products under its own brand portfolio, serving both medical and adult-use consumers through a network of branded dispensaries and delivery services.

Trulieve’s product lineup includes dried flower, vape cartridges, concentrates, edibles, tinctures and topicals, all of which are produced in compliance with state regulatory requirements. The company maintains proprietary cultivation facilities and in-house manufacturing labs to ensure quality control and consistency across its product offerings. In addition to its core brands, Trulieve has introduced specialty product lines focused on wellness and lifestyle applications.

Founded in 2015 and headquartered in Tallahassee, Florida, Trulieve was one of the first licensed medical cannabis providers in the state. Under the leadership of President and CEO Kim Rivers—who joined the company in 2016—the business has grown through a combination of organic expansion and strategic acquisitions. Notably, Trulieve completed the acquisition of Harvest Health & Recreation in 2021, significantly extending its footprint in key U.S. markets.

Today, Trulieve operates branded dispensaries and cultivation facilities across multiple states, including Florida, Massachusetts, Arizona, Pennsylvania and California. The company continues to focus on expanding its retail presence, refining its product portfolio and investing in research initiatives aimed at developing innovative cannabis-based therapies and consumer products.

AI Generated. May Contain Errors.

Receive TCNNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trulieve Cannabis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TCNNF Stock News Headlines

Elon’s S-1 Master Plan Could Rewrite the Rules of AI
A researcher who has advised Goldman Sachs, JPMorgan Chase, BlackRock, and Fidelity flew to Starbase after spotting a detail buried inside SpaceX's S-1 filing. Rob Spivey, Managing Director at Altimetry, says the discovery could reshape how investors view the AI economy, and he's naming the one stock positioned to benefit, not Tesla or SpaceX. The full briefing and stock name are free, with no credit card required.tc pixel
Trulieve Announces Share Repurchase Program
Trulieve Announces Uplist to NYSE
See More Headlines

TCNNF Stock Analysis - Frequently Asked Questions

Trulieve Cannabis' stock was trading at $8.66 at the start of the year. Since then, TCNNF stock has increased by 37.0% and is now trading at $11.86.

Trulieve Cannabis Corp. (OTCMKTS:TCNNF) released its quarterly earnings data on Monday, November, 15th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.27 by $0.13.

Shares of TCNNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/15/2021
Today
8/02/2026
Next Earnings (Estimated)
8/07/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:TCNNF
CIK
1754195
Fax
N/A
Employees
9,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:TCNNF) was last updated on 8/2/2026 by MarketBeat.com Staff.
From Our Partners